Morgan Stanley Operating Cash Flow decreased by 194.5% to -$7.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 70.4%, from -$23.98B to -$7.10B. Over 2 years (FY 2021 to FY 2024), Operating Cash Flow shows a downward trend with a -80.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.62B | $2.13B | $349.00M | $239.00M | $14.91B | -$7.55B | -$14.00B | -$9.87B | -$9.67B | -$17.75B | $4.36B | $2.53B | -$17.32B | $11.80B | -$23.98B | -$3.33B | -$2.41B | -$7.10B |
| QoQ Change | — | -53.9% | -83.6% | -31.5% | >999% | -150.6% | -85.3% | +29.5% | +2.0% | -83.7% | +124.6% | -42.1% | -786.1% | +168.1% | -303.2% | +86.1% | +27.7% | -194.5% |
| YoY Change | — | — | — | — | +223.1% | -454.9% | <-999% | <-999% | -164.8% | -26.8% | +144.2% | +126.1% | — | +166.5% | -649.9% | +80.8% | -120.4% | +70.4% |